Back to Journals » Clinical Ophthalmology » Volume 8

Probing of congenital nasolacrimal duct obstruction with dacryoendoscope

Authors Kato K, Matsunaga K, Takashima Y, Kondo M

Received 9 January 2014

Accepted for publication 4 February 2014

Published 16 May 2014 Volume 2014:8 Pages 977—980


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Kumiko Kato, Koichi Matsunaga, Yuko Takashima, Mineo Kondo

Department of Ophthalmology Mie University School of Medicine, Tsu, Japan

Background: A congenital nasolacrimal duct obstruction (CNLDO) is a relatively common disease in infants. We evaluated the results of probing three patients with CNLDO, under direct view, with a dacryoendoscope.
Methods: Three cases of CNLDO were examined and treated by probing with a dacryoendoscope, under intravenous anesthesia. The diameter of the dacryoendoscope probe was 0.7 mm, and we were able to observe the inner walls of the lacrimal duct and able to guide the probe through the duct.
Results: In all cases, the site of obstruction was detected, and the probe was used to remove the obstruction. At 2 weeks after the removal of the obstruction, there was no epiphora or mucopurulent discharge in any of the cases. No complications were detected intra- and postoperatively.
Conclusion: Although only three cases were studied, we believe that probing with a dacryoendoscope is a safe and effective method of treating a CNLDO. More cases need to be studied.

Keywords: probing, epiphora, mucoprulent discharge

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]